Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina N Fournier

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 12, 2022
Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial DesignChristina N Fournier
Neurology|June 13, 2023
AIMing for Better Tools to Track Disease ProgressionChristina N Fournier
Neurology|July 30, 2024
Learning From the Exception and Not the Rule: Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal PhenotypeChristina N Fournier
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 20, 2023
The importance of understanding minimal important difference for ALSFRS-R: A reply to 'Do we really need to calculate a minimal important difference for ALSFRS-R?' https://doi.org/10.1080/21678421.2023.2248199Christina N Fournier, Jonathan D Glass
JAMA Neurology|January 10, 2022
Unintended Consequences of Approving Unproven Treatments-Hope, Hype, or Harm?Jonathan D Glass, Christina N Fournier
Neurology|January 30, 2025
The Amyotrophic Lateral Sclerosis Multidisciplinary Clinic: Broke but Not BrokenChristina N Fournier, Colin C Quinn
Muscle & Nerve|May 10, 2025
The Necessity of Overcoming Racial Disparities in Amyotrophic Lateral Sclerosis Care and ResearchRocio Carolina Garcia Santibanez, Christina N Fournier
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 8, 2022
Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-RChristina N Fournier, Virginia James, Jonathan D Glass
Neurology|June 4, 2020
Tau deposition in the spinal cord is not specific for CTE-ALSChristina N Fournier, Marla Gearing, Jonathan D Glass
Neurology|September 19, 2018
Reader response: Pathologic ThrJonathan D Glass, Christina N Fournier, Marla Gearing
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 12, 2022
Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial DesignChristina N Fournier
Neurology|June 13, 2023
AIMing for Better Tools to Track Disease ProgressionChristina N Fournier
Neurology|July 30, 2024
Learning From the Exception and Not the Rule: Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal PhenotypeChristina N Fournier
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 20, 2023
The importance of understanding minimal important difference for ALSFRS-R: A reply to 'Do we really need to calculate a minimal important difference for ALSFRS-R?' https://doi.org/10.1080/21678421.2023.2248199Christina N Fournier, Jonathan D Glass
JAMA Neurology|January 10, 2022
Unintended Consequences of Approving Unproven Treatments-Hope, Hype, or Harm?Jonathan D Glass, Christina N Fournier
Neurology|January 30, 2025
The Amyotrophic Lateral Sclerosis Multidisciplinary Clinic: Broke but Not BrokenChristina N Fournier, Colin C Quinn
Muscle & Nerve|May 10, 2025
The Necessity of Overcoming Racial Disparities in Amyotrophic Lateral Sclerosis Care and ResearchRocio Carolina Garcia Santibanez, Christina N Fournier
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 8, 2022
Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-RChristina N Fournier, Virginia James, Jonathan D Glass
Neurology|June 4, 2020
Tau deposition in the spinal cord is not specific for CTE-ALSChristina N Fournier, Marla Gearing, Jonathan D Glass
Neurology|September 19, 2018
Reader response: Pathologic ThrJonathan D Glass, Christina N Fournier, Marla Gearing
Pageof 4